Literature DB >> 18481957

TCF7L2 controls insulin gene expression and insulin secretion in mature pancreatic beta-cells.

Merewyn K Loder1, Gabriela da Silva Xavier, Angela McDonald, Guy A Rutter.   

Abstract

Genetic studies have linked the risk of Type 2 diabetes with SNPs (single nucleotide polymorphisms) in the gene encoding the Wnt signalling-associated transcription factor, TCF7L2 (T-cell factor 7-like 2). The risk alleles have been associated with reduced glucose and GLP-1 (glucagon-like peptide 1)-stimulated insulin secretion. Recent evidence has suggested that inheritance of the at-risk T allele at SNP rs7903146 may increase the expression of TCF7L2 in adult human islets. However, the cellular mechanisms by which changes in TCF7L2 levels may affect insulin secretion are unclear. In the present paper, we describe the use of RNA silencing to investigate the role of TCF7L2 on insulin secretion and gene expression in rodent islets. We find that reduced TCF7L2 expression reduces glucose-simulated insulin secretion and insulin gene expression while slightly potentiating glucose stimulated changes in intracellular free Ca(2+) concentrations.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18481957     DOI: 10.1042/BST0360357

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  29 in total

Review 1.  On the origin of the beta cell.

Authors:  Jennifer M Oliver-Krasinski; Doris A Stoffers
Journal:  Genes Dev       Date:  2008-08-01       Impact factor: 11.361

2.  Alterations in TCF7L2 expression define its role as a key regulator of glucose metabolism.

Authors:  Daniel Savic; Honggang Ye; Ivy Aneas; Soo-Young Park; Graeme I Bell; Marcelo A Nobrega
Journal:  Genome Res       Date:  2011-06-14       Impact factor: 9.043

3.  R-spondin-1 is a novel beta-cell growth factor and insulin secretagogue.

Authors:  Victor S C Wong; Andrea Yeung; William Schultz; Patricia L Brubaker
Journal:  J Biol Chem       Date:  2010-05-04       Impact factor: 5.157

4.  R-spondin1 deficiency in mice improves glycaemic control in association with increased beta cell mass.

Authors:  V S C Wong; A H Oh; A A Chassot; M C Chaboissier; P L Brubaker
Journal:  Diabetologia       Date:  2011-04-12       Impact factor: 10.122

5.  Diabetes-associated genetic variation in TCF7L2 alters pulsatile insulin secretion in humans.

Authors:  Marcello C Laurenti; Chiara Dalla Man; Ron T Varghese; James C Andrews; Robert A Rizza; Aleksey Matveyenko; Giuseppe De Nicolao; Claudio Cobelli; Adrian Vella
Journal:  JCI Insight       Date:  2020-04-09

Review 6.  The role of incretins in glucose homeostasis and diabetes treatment.

Authors:  Wook Kim; Josephine M Egan
Journal:  Pharmacol Rev       Date:  2008-12-12       Impact factor: 25.468

7.  Lack of beta-catenin in early life induces abnormal glucose homeostasis in mice.

Authors:  S Dabernat; P Secrest; E Peuchant; F Moreau-Gaudry; P Dubus; N Sarvetnick
Journal:  Diabetologia       Date:  2009-06-10       Impact factor: 10.122

8.  Role of BMI in the Association of the TCF7L2 rs7903146 Variant with Coronary Heart Disease: The Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Anna M Kucharska-Newton; Keri L Monda; Suzette J Bielinski; Eric Boerwinkle; Thomas D Rea; Wayne D Rosamond; James S Pankow; Anna Köttgen; Gerardo Heiss; Kari E North
Journal:  J Obes       Date:  2010-02-22

9.  The T allele of rs7903146 TCF7L2 is associated with impaired insulinotropic action of incretin hormones, reduced 24 h profiles of plasma insulin and glucagon, and increased hepatic glucose production in young healthy men.

Authors:  K Pilgaard; C B Jensen; J H Schou; V Lyssenko; L Wegner; C Brøns; T Vilsbøll; T Hansen; S Madsbad; J J Holst; A Vølund; P Poulsen; L Groop; O Pedersen; A A Vaag
Journal:  Diabetologia       Date:  2009-03-14       Impact factor: 10.122

10.  Decreased TCF7L2 protein levels in type 2 diabetes mellitus correlate with downregulation of GIP- and GLP-1 receptors and impaired beta-cell function.

Authors:  Luan Shu; Aleksey V Matveyenko; Julie Kerr-Conte; Jae-Hyoung Cho; Christopher H S McIntosh; Kathrin Maedler
Journal:  Hum Mol Genet       Date:  2009-04-21       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.